Press Releases | Longboard Pharmaceuticals

Skip to main navigation

Corporate Menu

About
Pipeline
Investors
Careers
Contact

Press Releases

Year

September 21, 2021

Longboard Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference on September 28, 2021

September 8, 2021

Longboard Pharmaceuticals Successfully Completes LP352 Multiple Ascending Dose Portion of Phase 1 Clinical Trial in Healthy Volunteers, Plans to Initiate Phase 1b/2a Clinical Trial

August 31, 2021

Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences

August 9, 2021

Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results

May 10, 2021

Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results

March 11, 2021

Longboard Pharmaceuticals Announces Pricing of Initial Public Offering

January 21, 2021

Longboard Pharmaceuticals Appoints Brandi L. Roberts as Chief Financial Officer

January 20, 2021

Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors

October 28, 2020

Arena Pharmaceuticals Announces Launch of Longboard Pharmaceuticals With $56M Financing, Building a Novel Neuroscience Drug Development Company

©2021 Longboard Pharmaceuticals Privacy Policy | Terms of Use

Corporate Menu

About
Pipeline
Investors
Careers
Contact